ÃÑ 4558ÆäÀÌÁö

917ÆäÀÌÁö º»¹®½ÃÀÛ

³ó¸²Ãà»ê°Ë¿ª°Ë»ç±â¼ú°³¹ß»ç¾÷ 2015 ¿¬±¸º¸°í¼­
Comparison of hepatic toxicity of
acetaminophen and aflatoxin B1 among
0.4
human induced pluripotent stem cell-induced
°­È¯±¸
hepatocyte, primary hepatocyte and
HepG2(ASIATOX)
Effect of acetaminophen and aflatoxin B1 on
°­È¯±¸
0.4
hepatic differentiation from human
(°­¼®Áø)
pluripotent stem cell(ASIATOX)
Improvement of hepatic differentiation from
human induced pluripotent stem cells by
°­È¯±¸
0.4
removal of undifferentiated stem cells using
(ÀÌÇõ¹Ì)
YM155(ASIATOX)
Non-cytotoxic concentrations of aflatoxin B1
affect the development of hepatocyte
°­È¯±¸
±¹³»
0.2
progenitor cells to hepatocytes using human
(°­¼®Áø)
induced pluripotent stem
0.4
cell(Ãß°è´ëÇѼöÀÇÇÐȸ)
(2¡¿0.2)
Identifying Hepatotoxic Effects of Aflatoxin
°­È¯±¸
±¹³»
0.2
B1 on In Vitro Hepatogenesis using Human
(°­¼®Áø)
Induced Plruripotnet Stem Cell(Çѱ¹µ¶¼ºÇÐȸ)
°­È¯±¸
°­È¯±¸
0.5
±¹³»
0.5
2015 Çѱ¹µ¶¼ºÇÐȸ
Çмú¹ßÇ¥
(°­¼®Áø)
ÀÔ»ó
±¹¿Ü
1
¿ì¼ö¼º°ú
100¼±
-
3
¼±Á¤
À¯ÀüÀÚ¿ø
-
0.1
±âŹ
Áö»óÆÄ
3
(Áß¾ÓTV)
¶óµð¿À
0.5
Áß¾Ó
2
ÀÏ°£Áö
È«º¸¼º°ú
µ¿¹°¿ëÀǾàÇ° ¾ÈÀü¼º Æò°¡, ¿ªºÐÈ­ Áٱ⼼Æ÷·Î
0.4
Àü¹®Áö
0.4
°­È¯±¸
½ÇÇ赿¹° ´ëü
Áö¿ª
0.3
ÁÖ°£Áö
ÇØ¿ÜÈ«º¸
3
¥¶. ¿¬±¸»ç¾÷ ÃßÁø»ó ¹®Á¦Á¡ ¹× °ÇÀÇ»çÇ×
¥·. Áֿ俬±¸°úÁ¦ º¯°æ»çÇ×
916
³ó¸²Ãà»ê°Ë¿ªº»ºÎ

917ÆäÀÌÁö º»¹®³¡



ÇöÀç Æ÷Ä¿½ºÀÇ ¾Æ·¡³»¿ëµéÀº µ¿ÀÏÇÑ ÄÁÅÙÃ÷¸¦ °¡Áö°í ÆäÀÌÁö³Ñ±è È¿°ú¹× ½Ã°¢Àû È¿°ú¸¦ Á¦°øÇÏ´Â ÆäÀÌÁöÀ̹ǷΠ½ºÅ©¸°¸®´õ »ç¿ëÀÚ´Â ¿©±â±îÁö¸¸ ³¶µ¶ÇϽðí À§ÀÇ ÆäÀÌÁöÀ̵¿ ¸µÅ©¸¦ »ç¿ëÇÏ¿© ´ÙÀ½ÆäÀÌÁö·Î À̵¿ÇϽñ⠹ٶø´Ï´Ù.
»ó´Ü¸Þ´º ¹Ù·Î°¡±â ´ÜÃàÅ°¾È³» : ÀÌÀüÆäÀÌÁö´Â ÁÂÃø¹æÇâÅ°, ´ÙÀ½ÆäÀÌÁö´Â ¿ìÃø¹æÇâÅ°, ùÆäÀÌÁö´Â »ó´Ü¹æÇâÅ°, ¸¶Áö¸·ÆäÀÌÁö´Â ÇϴܹæÇâÅ°, ÁÂÃøÈ®´ëÃà¼Ò´Â insertÅ°, ¿ìÃøÈ®´ëÃà¼Ò´Â deleteÅ°